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Summary
Background: Actin cytoskeletal networks push and pull the
plasma membrane (PM) to control cell structure and behavior.
Endocytosis also regulates the PM and can be promoted or in-
hibited by cytoskeletal networks. However, endocytic regula-
tion of the general membrane cytoskeleton is undocumented.
Results: Here, we provide evidence for endocytic inhibition of
actomyosin networks. Specifically, we find that Steppke, a
cytohesin Arf-guanine nucleotide exchange factor (GEF), con-
trols initial PM furrow ingression during the syncytial nuclear
divisions and cellularization of the Drosophila embryo. Acting
at the tips of ingressing furrows, Steppke promotes local en-
docytic events through its Arf-GEF activity and in cooperation
with the AP-2 clathrin adaptor complex. These Steppke activ-
ities appear to reduce local Rho1 protein levels and ultimately
restrain actomyosin networks. Without Steppke, Rho1 path-
ways linked to actin polymerization and myosin activation
abnormally expand the membrane cytoskeleton into taut
sheets emanating perpendicularly from the furrow tips. These
expansions lead to premature cellularization and abnormal
expulsions of nuclei from the forming blastoderm. Finally,
consistent with earlier reports, we also find that actomyosin
activity can act reciprocally to inhibit the endocytosis at furrow
tips.
Conclusions: We propose that Steppke-dependent endocy-
tosis keeps the cytoskeleton in check as early PM furrows
form. Specifically, a cytohesin Arf-GEF-Arf G protein-AP-2
endocytic axis appears to antagonize Rho1 cytoskeletal path-
ways to restrain the membrane cytoskeleton. However, as
furrows lengthen during cellularization, the cytoskeleton gains
strength, blocks the endocytic inhibition, and finally closes off
the base of each cell to form the blastoderm.
Introduction
Coupling actomyosin networks to the plasma membrane (PM)
is essential for cells to migrate, interact, change shape,
and divide [1–5]. As examples, actin networks form and func-
tion at the leading edge of migratory cells, at cell-substrate
adhesion complexes, and at cell-cell adhesion complexes in
multicellular tissues. To assemble these complexes, receptors
can physically engage the actin cytoskeleton and also induce
cytoskeletal assembly via Rho- family guanosine triphosphate
(GTP)ases and phosphoinositide signaling [6, 7]. Inversely,
endocytosis can remove receptors from the PM promoting
the turnover of adhesion and signaling complexes [4, 8, 9].
More generally, the close links of both actin networks and
endocytic machinery with the PM suggest possible crosstalk
between these subsystems. Indeed, endocytic signaling*Correspondence: tony.harris@utoronto.canucleates local actin networks to help drive membrane invag-
ination and scission [10, 11]. In contrast, more widespread
membrane cytoskeleton activity can create tension that
inhibits membrane invagination [12, 13]. Conceivably, endocy-
tosis could also inhibit the membrane cytoskeleton, but such
activity is undocumented.
The syncytial Drosophila embryo is a well-established
model for studying actomyosin networks and membrane traf-
ficking during PM furrow ingression. In the early syncytial
embryo, nuclei divide synchronously just beneath the PM.
At each division cycle, the activities of Rho-family GTPases
[14–16], the Arp2/3 complex [17, 18], and the formin Diapha-
nous (Dia) [19] organize actomyosin-based PM ingressions
(pseudocleavage furrows) that surround each nucleus to pre-
vent nuclear collision and loss. Once w6,000 nuclei form,
similar mechanisms induce a final round of PM ingressions.
These furrows persist and elongate through membrane traf-
ficking to apical and lateral sites [20–22], and with support of
actomyosin networks at their basal tips (the furrow canals)
[21, 23]. This massive PM growth cellularizes the first embry-
onic epithelium, a process completed with constriction of
actomyosin rings formed at the base of each cell [21, 23].
Recently, endocytic events were detected at the tips of
pseudocleavage furrows and early cellularization furrow ca-
nals by the presence of Amphiphysin (Amph)-positive tubules
and the internalization of labeled PM [24]. These events have
provided a model for studying how the actin cytoskeleton
can both promote and inhibit endocytosis [24, 25]. However,
the role of this endocytosis is unclear, and paradoxically, it
would appear to counteract membrane growth. We examined
how Arf G protein (Arf) activation might be involved. In other
contexts, Arfs promote endocytosis by recruiting coat pro-
teins, activating lipid signaling, and triggering actin poly-
merization [26–29]. Like other G proteins, Arfs are activated
by guanine nucleotide exchange factors (GEFs). Cytohesins
are a major class of PM Arf-GEFs [27], and roles for cytohesin
Arf-GEFs have been documented at migratory leading edges,
focal adhesions, and adherens junctions in mammalian cell
culture [30–32]. Drosophila contains one cytohesin, called
Steppke (Step) [26]. Step is known to function in postembry-
onic insulin and EGF signaling [33, 34], which mammalian
cytohesins do as well [27, 35], but its contributions to
the Drosophila embryo and to other cellular processes are
unknown. Here, we show that Step promotes endocytosis
at pseudocleavage furrows and furrow canals to restrain acto-
myosin networks at these sites.
Results
Step Promotes Endocytic Tubules and Restrains
the Cytoskeleton at PM Furrows
To test how Step affects endocytosis at cellularization furrow
canals, we began by perturbing maternal supplies of Step
and used Amph as a probe for endocytosis. In wild-type
(WT), Amph-positive tubules emanate from early furrow canals
(Figure 1A, arrows) and tubule numbers decrease as furrows
lengthen (Figure 1A) [24]. We performed loss-of-function ex-
periments with maternally supplied step short hairpin RNA
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2111(shRNA) or with females transheterozygous for two hypomor-
phic alleles with a 93% reduction of maternal step mRNA [33]
and analyzed progeny at early cellularization. The tubules were
largely abolished in both cases (Figure 1A).
Since endocytosis and the PM are intimately linked, we
probed PM organization. step loss-of-function embryos dis-
played abnormal expansions of furrow canal PM (seen with
Amph staining [Figure 1B] and the PM markers Discs large
[Dlg] [see also Figure S1A available online] and DE-cadherin
[data not shown]). The membranes expanded as taut, thin
sheets perpendicular to the ingressing furrows and invaded
space normally occupied by nuclei, which clustered abnor-
mally, constricted in the plane of the expanded membrane,
or were lost (Figures 1B–1E). Across populations of embryos,
the tubule loss appeared more penetrant than the PM expan-
sion (Figure S2A). Most embryos failed to recover from these
defects, and substantial lethality occurred (Figure S2B).
The PM expansion with step loss of function (Figure 1B) was
consistent with a decrease to endocytosis but also partially
mimicked the bottleneck mutant phenotype, in which pre-
mature actomyosin constriction expels nuclei from the pre-
sumptive epithelium [36]. To test if Step also counteracts
actomyosin networks, we probed actin in step loss-of-function
embryos. In early WT embryos, furrow canal F-actin is orga-
nized as a ring that emanates short bundled filaments
connecting to F-actin on the upper portion of the furrows
(Figure 1C). At early cellularization in step loss-of-function
embryos, F-actin appeared normal over the upper furrow
membrane but spread perpendicularly into taut, thin networks
at the furrow canals (Figure 1C), as seen for the PM. The total
intensity of F-actin staining was elevated at the level of
the furrow canals in step loss-of-function embryos versus
WT (Figure S3), and the expanded membranes were also
coated with the septin Peanut and Anillin (Figure S1B). Nuclei
were displaced above and below the expanded actin net-
works, with some pinched into bottle-like shapes (Figure 1D).
Thus, without Step, the furrow canal membrane cytoskeleton
abnormally expands while remaining a taut sheet that dis-
places nuclei from the forming epithelium (Figure 1E).
The reduced number of nuclei and the variability of the
membrane expansions in cellularizing step loss-of-function
embryos contrasts the bottleneck cellularization phenotype
[36] and suggested defects during earlier syncytial nuclear
divisions (specifically during cycles 10–13, when the nuclei
localize to the embryo periphery and engage the PM). Indeed,
live imaging of Zipper-GFP (Zip-GFP; nonmuscle myosin II
heavy chain) revealed abnormal expansion of actomyosin
networks at ingressing furrows starting typically at the second
peripheral nuclear division (cycle 11) (Figure 2A). This ex-
pansion appeared to precede major nuclear loss and then
increased progressively through the remaining division cycles
and into cellularization (Movies S1, S2, and S3). As in WT,
Zip-GFP networks disassembled at each metaphase in step
loss-of-function embryos (Movies S1, S2, and S3; Figure 2B,
although incomplete disassembly was observed in severely
disrupted embryos [red asterisks]), suggesting myosin II inhi-
bition by Cdc2 [37] is independent of Step. With Step loss,
the early expanded networks had significantly greater total
Zip-GFP fluorescence than WT (Figure 2A), a difference that
was maintained into cellularization (Figure S3). Side views
showed that the networks expanded only in the plane of the
furrow tips (Figure 2B) and that furrow ingression was often
disrupted (Figure 2B, red arrows). Zip-GFP displayed local in-
tensity fluctuations within the abnormally expanded networks(Movie S3), suggestive of local myosin II contractions within
broad actomyosin networks. The progressive actomyosin
network buildup coincides specifically with when endocytosis
normally occurs at ingressing furrows during syncytial nuclear
divisions and cellularization [24], and we found that Amph
tubule numbers were also decreased at pseudocleavage
furrows of step loss-of-function embryos (Figure 2C). Thus,
the timing of the step phenotype is distinct from that of
bottleneck, which specifically functions at cellularization [36].
Instead, Step appears to promote endocytosis and inhibit
actomyosin networks at all early PM ingressions of the syncy-
tial embryo.
Step Antagonizes Rho1 Pathway Activity at PM Furrows
To test if the step loss-of-function phenotype is due to actomy-
osin overactivity, we attempted to suppress it by weakening
actomyosin networks. The Rho1 pathway promotes actin
polymerization through formins and activates myosin II [38],
and, as discussed, these pathways promote pseudocleavage
and cellularization furrow stability. Thus, we tested whether
a reduction in Rho1 activity could suppress the step loss-of-
function phenotypes.Maternal heterozygosity for rho172O sup-
pressed the step RNAi furrow canal expansion and nuclear
loss phenotypes to nearly WT (Figure 3A; Figures S4A and
S4B; also seen for rho172F [data not shown]). To assess the
Rho1 pathway involved, we examined step RNAi embryos
derived from mothers heterozygous for either dia5 (the
Drosophila formin regulated by Rho1) or zip1 alone but ob-
served no suppression (data not shown). However, hetero-
zygosity for both dia5 and zip1 suppressed the step RNAi
furrow canal expansion and nuclear loss phenotypes sub-
stantially, albeit more weakly than the heterozygosity for
rho172O (Figure 3A; Figures S4A and S4B). The suppression
of the abnormal furrow canal expansion in these experiments
argues that Step normally antagonizes Rho1-induced actin
polymerization and myosin II activation at PM furrows. The
suppression of the abnormal nuclear loss further indicates
that this antagonism occurs at furrows throughout the nuclear
division stages and into cellularization.
To investigate how Step antagonizes the Rho1 pathway, we
began by probing Rho1 protein localization in step RNAi and
WT embryos at early cellularization. Both showed weak Rho1
staining over furrow canalmembranes (Figure 3B), but the total
intensity was greater for step RNAi embryos (Figure S3). One
concern was that more Rho1 was detected at the furrow
canals of step RNAi embryos as a nonspecific consequence
of the expanded furrow canal membranes in these embryos.
To separate the analysis of Rho1 levels from the effects of
elevated actomyosin activity on membrane architecture, we
analyzed step RNAi embryos derived from mothers hetero-
zygous for both dia5 and zip1, in which the furrow expansion
phenotype was suppressed. Strikingly, for similarly sized
membranes, furrow canal Rho1 levels were higher in the sup-
pressed step RNAi embryos versus WT (Figure 3C; maternal
heterozygosity for both dia5 and zip1 without step RNAi had
no effect on Rho1 levels, Figure 3D). Since RhoGEF2 is the
main upstream recruiter of Rho1 to furrow canals [14, 16], we
tested its localization but observed no change between the
genotypes, in contrast to counterstained Rho1 (Figure 3E).
To address the possibility that the higher Rho1 levels could
be linked to a residual elevation of F-actin in the suppressed
step RNAi embryos, we quantified furrow canal phalloidin
staining levels, but they were indistinguishable between
similarly sized membranes of each genotype (Figure 3F).
Figure 1. Step Is Required for Endocytic Tubule Formation and Membrane Cytoskeleton Restraint
(A) 3D surface renderings of Amph staining. Endocytic tubules (arrows) are reduced with step loss. Embryos with similar overall morphologies shown to
highlight tubules. Below, quantification includes all cellularization morphologies (see Supplemental Experimental Procedures). Furrow lengths are based
on plasma membrane (PM) Amph staining excluding tubules. p values from t tests of tubules/cell for all furrow lengths are shown.
(B) Expansion of Amph-positive furrow canal PM with step RNAi (red arrows) versus wild-type (WT). Mild and severe step RNAi phenotypes are shown.
(legend continued on next page)
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Figure 2. The step Phenotype Begins during the Peripheral Syncytial Nuclear Divisions
(A) Timeframes of 3D projections show mild and severe expansions of Zip-GFP networks in step mutants versus WT from the second or third peripheral
nuclear division (cycles 11 and 12) through cellularization (Movies S1 and S2). Data were collected and adjusted with the same settings. Below, Zip-GFP
levels quantified at cycle 12 prophase (p = 0.027 for t test of mean intensities of each embryo).
(B) Side views of the embryos shown in (A) through cycles 11–13 reveal that the expanded Zip-GFP networks are at the tips of pseudocleavage furrows
(white arrows in control). Note, however, defects in furrow ingression occurred in step mutants (red arrows). Also, in WT, PM myosin II is normally lost at
metaphase of each cycle [37], but in severely affected step mutants, some Zip-GFP persisted (asterisk). Similar overall results were seen with Zip-GFP
in step RNAi embryos (data not shown).
(C) Loss of Amph-positive tubules, expansion of Amph-positive PM at furrow tips, and loss of nuclei in step mutants versus control at cycle 13. Data are
quantified at right with means 6 SD for step mutants and RNAi.
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through a mechanism independent of both local RhoGEF2
levels and effects on actomyosin networks.
Since weakening the Rho1 pathway suppressed the step
loss-of-function phenotype, we predicted that directly stabi-
lizing actin would mimic the phenotype. Thus, we treated
permeabilized Zip-GFP embryos with the F-actin stabilizer
jasplakinolide and analyzed early cellularization. In contrast
to carrier control, the treatment led to binding of jasplakinolide(C) Expansion of phalloidin-stained F-actin at furrows canals (arrows; 0 mm) w
are shown to cluster (blue asterisks) or shrink (pink asterisks).
(D) Nucleoporin 50-positive nuclei in step RNAi embryos are displaced above
furrow canals, versus WT. For (B)–(D), similar effects were seen in step mutan
(E) Schematics of furrow membranes (gray), Amph-positive tubules (blue), andto F-actin (Figure S5B), increased Zip-GFP levels (Figures S5A
and S5C), furrow canal PM expansion (Figures S5A, S5B, and
S5D), and nuclear loss (Figure S5B). The similarity of these
effects to the defects observed with step loss-of-function
further argues that the step loss-of-function phenotype
is due to excess actomyosin. Note, however, that the furrow
expansion is milder and more even across the embryo with
the jasplakinolide treatment than with the loss of Step. In
part, this difference can be attributed to the timing of theith step RNAi versus WT. In (B) and (C), intervening nuclear compartments
or below, or pinched into bottle-like shapes (arrows) by, F-actin-enriched
ts (data not shown).
F-actin (green).
Figure 3. The step Phenotype Is Ultimately Due to Elevated Rho1 Pathway Activity
(A–F) Early cellularization.
(A) Amph staining. The step RNAi phenotype is shown alone or suppressed with maternal heterozygosity for rho172O or for both dia5 and zip1. Arrows mark
tubules.
(B) Rho1 localizes over expanded furrow canal PM of a step RNAi embryo versus WT. Local Rho1 levels are indistinguishable. The difference in total furrow
canal Rho1 levels is quantified in Figure S3.
(C) Suppressed step RNAi embryos from mothers heterozygous for both dia5 and zip1. Local Rho1 levels are higher than WT furrow canal membranes of
similar size from internal controls.
(D) Maternal heterozygosity for both dia5 and zip1 alone has no effect on Rho1 furrow canals levels versus internal control.
(E) Suppressed step RNAi embryos from mothers heterozygous for both dia5 and zip1 with internal control. Costaining Rho1 and RhoGEF2 shows the
abnormal increase of Rho1 levels occurs without a corresponding increase in RhoGEF2 levels.
(F) Suppressed step RNAi embryos from mothers heterozygous for both dia5 and zip1 with internal control. No difference in F-actin levels was detected.
(C–F) Quantifications were normalized to the average internal WT control level in each costaining experiment.
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30 min period during cellularization and the Step loss affecting
all syncytial stages.Of note, Amph-positive tubules were also lost with the
jasplakinolide treatment and, to a lesser extent, with the carrier
control (Figures S5A and S5E). This result suggests that
Figure 4. GFP-Step Localizes to Furrow Canals
and Acts through Arf Activation to Antagonize
the Membrane Cytoskeleton
(A) GFP-Step is enriched at early furrow
canals and destabilizes furrows (brackets).
GFP-StepE173K (Arf-GEF inactive) is enriched at
early furrow canals but has no effect on furrows.
0 mm set just below furrow canals for reference,
and z sections are shown at 0.6 mm intervals
above this point.
(B) Loss of phalloidin-stained F-actin from furrow
canals with GFP-Step overexpression (arrows)
versus WT and GFP-StepE173K overexpression.
(C) RNAi-resistant GFP-Step can rescue step
RNAi-induced Amph-positive tubule loss, furrow
canal PM expansion, and nuclear loss, but RNAi
resistant GFP-StepE173K cannot.
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canals. Similarly, Amph-positive tubule numbers and mor-
phology were restored in step RNAi embryos with maternal
heterozygosity for rho172O (Figure 3A; Figure S4C), suggesting
that some endocytosis can occur with step loss of function but
is inhibited by abnormal actomyosin elevation. These data and
other reports of actin inhibiting endocytosis at furrow canals
in this system [24, 25] made it important to distinguish two
main models for how Step could function: (1) as a promoter
of endocytosis that in turn inhibits the membrane cytoskel-
eton, or (2) as an inhibitor of the membrane cytoskeleton that
otherwise inhibits endocytosis.
Step Localizes to Furrows and Restrains the Cytoskeleton
via Its Arf-GEF Activity
To further probe how Step functions and to begin to distin-
guish if its primary effects are on endocytosis or on the acto-
myosin cytoskeleton, we constructed and overexpressed
GFP-Step and GFP-StepE173K with an inactivating mutation
in its Arf-GEF domain [39, 40]. Both proteins localized along
early cellularization furrows with furrow canal enrichment
(Figure 4A), overlapping partially with Amph at furrow canals,
but with no detection at the tubules. Intriguingly, 55% (72/
131) of GFP-Step embryos had furrows of varying lengths
(Figure 4A), suggesting local defects in furrow formation or
stability, and ultimately most die as embryos (Figure S2B).
We noted thatmore severe phenotypes correlatedwith greater
GFP-Step levels at the furrows (data not shown). In contrast,
GFP-StepE173K embryos extended furrows normally and syn-
chronously (Figure 4A; 2/84 had shortened furrows), despite
equal or greater GFP-StepE173K levels at furrows, and had
background embryonic lethality (Figure S2B).
The furrow loss with Step overexpression resembled that of
mutants with weakened actin networks such as nullo [41, 42],
nuclear fallout [15, 43], rhoGEF2 [14], dia [19], SCAR [18],
mutants disrupting Arp2/3 [17, 18], and others [23]. Thus, weprobed F-actin at early furrow canals.
In WT embryos, F-actin was strongly
enriched at each furrow canal, whereas
furrow canal F-actin levels were variable
in 12/24 GFP-Step embryos, suggestive
of local destabilizations, but not in
7/7 GFP-StepE173K embryos (Figure 4B).
These results suggest that Step impacts
actomyosin networks through its Arf-
GEF activity.To further validate the constructs and test the role of Step
Arf-GEF activity, we made RNAi-resistant forms of GFP-Step
and GFP-StepE173K and coexpressed them maternally with
step shRNA. Expression of RNAi-resistant GFP-Step sub-
stantially rescued the step RNAi furrow canal expansion and
nuclear loss phenotypes (Figure 4C; 21/25 embryos resembled
WT; 3/25 had the Step overexpression phenotype; and 1/25
had the step RNAi phenotypes). We noted that the rescue
occurred over a range of GFP-Step levels at the furrows
(data not shown). In contrast, RNAi-resistant GFP-StepE173K
failed to rescue the step RNAi phenotypes (Figure 4C; 6/45
embryos resembledWT and 39/45 had stepRNAi phenotypes)
despite equal or greater levels at furrows. These PM com-
parisons indicate that Step Arf-GEF activity is critical for regu-
lating PM furrows, and the nuclear loss comparisons argue
that this regulation occurs throughout the nuclear division
stages and into cellularization.
Step Acts with AP-2a to Restrain the Membrane
Cytoskeleton
One way that Arfs promote endocytosis is through the recruit-
ment of coat proteins. In mammalian cells, Arfs can recruit
clathrin and its adaptor complex AP-2 [44–46]. Thus, we pur-
sued the AP-2 a subunit (AP-2a), beginning with maternal
shRNA experiments. AP-2a shRNA led to two main classes
of PM furrow defects, in contrast to the WT appearance of
control shRNA embryos. The first main class included various
degrees of furrow loss (Figures 5A and 5B) consistent with
known roles of endocytosis and membrane recycling in fuel-
ling furrow growth [22]. Strikingly, the second main class
involved abnormal PM expansions, specifically at furrow tips
at both cellularization and earlier syncytial divisions (Figures
5A and 5B). This second class of embryos also lacked
Amph-positive tubules (Figure 5A; 18/22 cellularization and
precellularization embryos with furrow lengths below 4 mm
showed a marked reduction in tubules versus controls).
Figure 5. Step Cooperates with AP-2a to Antagonize the Membrane Cytoskeleton
(A) Comparison of Amph staining in a control mCherry RNAi early cellularization embryo with intact furrows, intact nuclei, and Amph-positive tubules
(arrows) to an early cellularization AP-2a RNAi embryo with expanded PM at its furrow tips and a lack of Amph-positive tubules, and to an AP-2a RNAi em-
bryo with furrow loss (furrow loss prevented precise staging, but peripheral nuclei were apparent by exclusion of Amph).
(B) Distributions of all cellularization and precellularization embryoswith any furrows into the five phenotypes indicated for controlmCherryRNAi andAP-2a
RNAi embryos alone or with maternal heterozygosity forAP-2s or step alleles. The percentages of embryoswith defects similar to those foundwith step loss
of function are indicated with bars beside the red and orange categories.
(C) AP-2a staining. A step RNAi embryo is shown alone or suppressed with maternal heterozygosity for rho172O, both compared with internal controls.
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AP-2sKG02457 allele increased the proportion of embryos in
each of the classes (Figure 5B; control shRNA in mothers het-
erozygous for the AP-2sKG02457 had no effect on the classes),
suggesting roles for the overall AP-2 complex in both fuelling
and restraining furrow growth. Moreover, expression of AP-
2a shRNA in mothers heterozygous for the strong stepK08110
allele [33] increased the proportions of embryos in each class,
and expression in mothers heterozygous for the weak
stepSH0323 allele [33] increased the proportion of embryos
with furrow loss (Figure 5B; control shRNA in mothers mater-
nally heterozygous for these alleles produced neither class).
The similarity of the PM expansions in both step and AP-2a
loss-of-function embryos and the enhanced phenotype with
double disruption argue that Step acts with AP-2a to restrainthe membrane cytoskeleton at furrow tips. Also, Step appears
to contribute to AP-2 function in furrow growth, although
step loss-of-function embryos did not display furrow loss on
their own.
To test if Step is required for recruiting AP-2 to furrow
canals, we first stained for AP-2a in WT and step RNAi em-
bryos at early cellularization. Lateral AP-2a levels were similar
in each case, but furrow canal levels were difficult to compare
because of the abnormally expanded PM with step RNAi
(Figure 5C). To compare furrows with similar overall structure,
we examined step RNAi embryos from mothers heterozygous
for rho172O. At early cellularization, both these suppressed
embryos and controls displayed indistinguishable lateral
localization and furrow canal enrichment of AP-2a (Figure 5C).
Thus, AP-2a recruitment to furrows and furrow canals appears
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line injections of fluorescently tagged wheat germ agglutinin
(WGA) to label the outer surface of the apical PM and observed
live endocytic events from invaginating furrows in both WT
and step RNAi embryos (Figure S6). Thus, the loss of Step
does not eliminate general endocytosis at the PM furrows.
Rather, the cooperation of Step and AP-2a in restraining the
membrane cytoskeleton appears to represent one aspect of
overall AP-2 activity.
Step Can Induce Ectopic Endocytic Activity at Furrow
Tips without Apparent Effects on Actin
Since the canonical role for PM Arfs and AP-2 is the induction
of endocytosis, we hypothesized that Step primarily promotes
endocytosis that in turn inhibits actomyosin networks. As an
additional test of this model, we asked if GFP-Step could
induce ectopic endocytosis at furrowcanals and, if so,whether
this effect would coincide with a decrease in furrow canal F-
actin or not. At later cellularization, Amph-positive tubules
are normally lost from furrow canals [24] (Figure 6B). Over-
expressed GFP-Step and GFP-StepE173K became strongly
enriched at these later furrow canals (Figure 6A). Focusing on
embryos that passed earlier cellularization without apparent
defects, we found that GFP-Step induced ectopic tubules
at later furrow canals, whereas GFP-StepE173K had a slight
dominant-negative effect (Figure 6B). Counterstaining for Dlg
confirmed that the induced Amph-positive tubules extended
below the base of the PM furrows (Figure 6C, arrows; also
confirmed with Neurotactin as a PMmarker [data not shown]).
We also stained for AP-2a in this class of embryos and found
elevated staining at furrow canals of GFP-Step-overexpress-
ing embryos, but not GFP-StepE173K-overexpressing embryos,
versusWT (Figure 6D). To test if the elevated endocytic activity
arose because of F-actin disruption by GFP-Step, we probed
actin in GFP-Step and WT embryos at mid-late cellularization
but found no effects on furrow canal phalloidin staining level
or pattern regardless of GFP-Step expression level (Figure 6E).
Similarly, we observed no effects on the septin Peanut (data
not shown). These results contrast effects seen in nullo and
dia mutants, in which abnormally high tubule numbers are
found at later cellularization but coincide with abnormally low
furrow canal F-actin levels [16, 24, 25, 41]. Our data indicate
that Step Arf-GEF activity can induce endocytic activity at
furrow canals without apparent actin inhibition.
Discussion
Our data provide the first description of cytohesin function in
a developing embryo. We find that Drosophila Step promotes
a subset of endocytic events at the tips of ingressing PM
furrows during embryo cellularization. Endocytosis has been
documented previously at these sites [24], but its role has
been unclear. Bymanipulating a conserved upstream activator
of endocytosis, we identify an important role of endocytosis
in controlling the membrane cytoskeleton. Our data argue
that Step acts at furrow tips to induce local Arf-dependent
endocytosis, which in turn antagonizes Rho1-dependent
actomyosin network assembly at these sites (Figure 6F).
We also find that the cytoskeleton can inhibit endocytosis at
the furrow tips, as has been previously shown in this system
[24, 25] and in other contexts [12, 13]. We propose an overall
model in which this reciprocal relationship is one-sided at spe-
cific developmental stages. At newly forming PM furrows, Step
dominates, promoting endocytosis that keeps cytoskeletonactivity in check for proper pseudocleavage and cellularization
furrow architecture and growth. During later cellularization,
the cytoskeleton dominates. Zygotic expression of actin regu-
lators such as Nullo normally increases actomyosin activity
as cellularization proceeds [41] and appears to work in
conjunction with Dia to block endocytic events at the furrow
tips [24, 25]. By counteracting the inhibitory endocytosis,
cytoskeletal activity would elevate further but at these later
stages is locally restrained by a distinct mechanism requiring
Bottleneck [36]. To form the blastoderm, this second restraint
mechanism is removed, and contractile rings close off the
base of each cell. In the absence of the initial Step-mediated
restraint mechanism, we propose that the cytoskeleton abnor-
mally dominates the relationship at all early PM furrows.
Without Step-based endocytic inhibition, we speculate that
actomyosin networks abnormally expand and inhibit other
endocytic events leading to coexpansion of cytoskeletal poly-
mers and PM from the furrow tips.
An important element of the model is the local induction
of endocytic events. Our data localize Step to the tips of
ingressing PM furrows, and both the loss and overexpression
of Step alter membrane organization specifically at these
sites. This localized Step-regulated activity occurs in a dy-
namic global membrane trafficking system within each form-
ing cell. During the peripheral nuclear divisions, each nucleus
acquires its own endoplasmic reticulum and Golgi apparatus
that function with recycling endosomes to direct exocytosis
to growing PM furrows at cellularization [22, 47, 48]. Simulta-
neously, endocytic events occur over the apical PM and at
the furrow tips [22, 24, 25], with endocytosedmaterial recycled
to the growing furrows [22]. Thus, the overall membrane sys-
tem is in continual flux, and coordination by local regulation
would be expected. Our data identify a polarized endocytic
activator required for the process. Step Arf-GEF activity is
critical for restraining the membrane cytoskeleton at furrow
tips, and a subset of AP-2 activities is involved as well.
How could endocytosis and actomyosin networks impact
each other at the tips of PM furrows or elsewhere? This ques-
tion can be considered from several levels of organization.
First, a simple and direct connection could be endocytic
removal of one or more PM actomyosin regulators. Our work
identifies Rho1 or an upstream regulator as a candidate.
Intriguingly, membrane trafficking has been previously
linked to the Rho1 pathway in this context. Specifically, recy-
cling endosomes have been implicated in the trafficking of
RhoGEF2 to the PM [15]. We hypothesized that RhoGEF2
might also be a target of Step for its removal from the PM
but found no difference in RhoGEF2 levels at furrow canals
in step loss-of-function embryos. Thus, Rho1 may be a more
specific target of Step, although a direct connection to the
Rho1 pathway remains to be determined. Of note, a number
of septins have also recently been observed on the Amph-
positive tubules [49].
Second, interplay between different pools of actin is
possible. For example, actin contributes to the invagination
and scission of endocytic vesicles [11, 24], and thus, endocytic
actin and other PM actin networks could compete for regula-
tors or components. Additionally, there could be signaling
crosstalk between regulators of the different networks. For
example, Arf signaling often elicits local Rac or Cdc42 activity
[29, 50], and this might trigger crosstalk affecting Rho activity
[51]. Interestingly, overexpression of Cdc42-interacting pro-
tein 4 (Cip4) appears to antagonize Dia at furrow canals,
although Cip4 mutants have no cellularization phenotype on
Figure 6. Step Can Induce Endocytosis without Apparent Membrane Cytoskeleton Disruption
(A–E) Embryos able to develop to mid-late cellularization without furrow loss.
(A) GFP-Step and GFP-StepE173K become highly enriched at phalloidin-stained furrow canals.
(B) 3D surface renderings of Amph staining show the endocytic tubules (arrows) induced by GFP-Step overexpression versus WT and the dominant-
negative effect of GFP-StepE173K. The data are quantified below. Furrow lengths are based on PMAmph staining excluding the tubules. p values from t tests
of tubules/cell for all furrow lengths shown.
(C) The Amph tubules induced by GFP-Step extend below the base of the Dlg-stained PM (arrows).
(D) AP-2a levels increased at furrow canals by GFP-Step, versus internal WT control, but not by GFP-StepE173K. This is apparent in side views comparing
top of furrows to furrow canals (yellow arrow). The change was also apparent in single xy sections at furrow canals (quantified at right over populations of
embryos; results reproducible over two to three staining experiments).
(E) Furrow canal phalloidin staining was indistinguishable between GFP-Step overexpressing and internal WT controls regardless of GFP-Step levels
(GFP-Step and phalloidin measured at the same furrow canal sites; quantified from two experiments).
(F) A model of Steppke-regulated endocytic antagonism of the membrane cytoskeleton during early PM furrow formation (shown for cellularization).
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2119their own [25]. Significantly, however, we find that Step
acts with AP-2 to control the membrane cytoskeleton. This
Step-AP-2 cooperation suggests that clathrin-coated pits are
involved in the antagonism, although it does not exclude the
possibility of separate cytoskeletal crosstalk.
Third, larger scale interactions should be considered. Endo-
cytosis could remove membrane in bulk that would otherwise
support the membrane cytoskeleton, although our observa-
tions of residual furrow canal endocytic activity with step
loss of function suggest amore specificmechanism. Inversely,
the membrane cytoskeleton could block endocytosis by
elevating PM tension [12, 13] or possibly by sterically blocking
endocytic machinery from accessing the PM.
Endocytic-cytoskeletal crosstalk is relevant to many cellular
processes. For example, receptor endocytosis occurs in prox-
imity to actomyosin networks in various contexts, including
migratory leading edges, focal adhesions, and adherens junc-
tions [4, 7–9]. However, these endocytic events and acto-
myosin networks have mainly been studied independently,
and thus their functional integration is not understood. Our
work highlights the possibility that endocytic activity at
such assemblies could simultaneously remove receptors and
antagonize local cytoskeletal networks, with both effects pro-
moting complex turnover and cellular dynamics.
Experimental Procedures
RNAi, mutant, and overexpression studies were conducted using standard
Drosophila genetic approaches. Other embryo manipulations also followed
standard methods. Embryo imaging was done with z stacks with 300 nm
step sizes with a spinning-disk confocal system (Quorum Technologies) at
room temperature with a 633 Plan Apochromat NA 1.4 objective (Zeiss), a
piezo top plate, an electron-multiplying charge-coupled device (EM CCD)
camera (Hamamatsu Photonics), and Volocity software (PerkinElmer). All
Drosophila stocks, reagents, postacquisition image analyses, quantifica-
tions, and detailed methods are described in the Supplemental Experi-
mental Procedures.
Supplemental Information
Supplemental Information includes six figures, Supplemental Experimental
Procedures, and three movies and can be found with this article online at
http://dx.doi.org/10.1016/j.cub.2013.08.058.
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